Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Pie charts showing the breakdown of the OTC market in Britain in 2016

A breakdown of the over-the-counter medicines market in Britain in 2016Subscription

By

The over-the-counter medicines market grew by 2.3% during 2016 to reach £2.62bn.

See more infographics

Editorial

Jenga blocks symbolising risks and opportunities for the UK drug regulator post-brexit

Drug regulation in the UK: risks and opportunities post-BrexitSubscription

While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.

Comment

Scientists pushing pills around model human body

Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription

By

The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.

Q&A

Pill under microscope lens

Restricting what is allowed on prescription in England: views from healthcare professionals and patient groupsSubscription

By

We ask healthcare professionals across primary care and patient groups for their thoughts on NHS England’s decision to review what GPs are allowed to prescribe.

Books and Arts

Cover of the book "Introduction to drug disposition and pharmacokinetics"

Basic introduction to knowledge and skills required in new drug developmentSubscription

By

Introduction to drug disposition and pharmacokinetics, by Stephen H Curry and Robin Whelpton

Cover of the book ‘The case against sugar’

Building a case on the harm of sugarSubscription

By

The case against sugar, by Gary Taubes

Learning article

Close up of a health worker examining a toddler's ear

How to diagnose and manage primary and secondary earache and ear infectionsSubscription

By

Earache is a common problem that can be the result of a variety of different pathologies. It is important for pharmacists and healthcare professionals to appropriately diagnose primary and secondary earache and ear infections.

Close up of a man using a tongue scraper

Advising patients on halitosis and oral hygieneSubscription

By ,

Halitosis (bad breath) is estimated to be the third most frequent reason for patients to seek dental care, following tooth decay and gum disease. Pharmacists are ideally placed to promote oral health and provide patients with advice on the prevention and management of halitosis.

Careers

Sini Eskola, regulatory affairs director at the European Federation of Pharmaceutical Industries and Associations (EFPIA)

What pharmacist Sini Eskola does at the European Federation of Pharmaceutical Industries and Associations (EFPIA)Subscription

By

Forming a view on complicated matters, involving legislation and policy, which influence many parts of pharmaceutical industry businesses, is an important challenge, says Sini Eskola.

Road with a three-way sign painted on pavement

From pharmacy technician to pharmacistSubscription

By

There is no easy career path for pharmacy technicians who want to become pharmacists. Steve Hemsley finds out more about the process and how some technicians have made it work.

John Mowat, multi-site pharmacy manager for LloydsPharmacy and lead pharmacist based in the Carleton Clinic, a mental health hospital in Carlisle

My life as a mental health pharmacist in a specialist hospital

By

As a multi-site pharmacy manager for LloydsPharmacy and lead pharmacist based in the Carleton Clinic, a mental health hospital in Carlisle, John Mowat talks about his career and role in providing the medication supply service for Cumbria Partnership Foundation Trust.

News

High Court judge Mr Justice Singh

High Court throws out legal challenge over GPhC standards but PDA says ruling provides “welcome clarification”

The Pharmacists’ Defence Association (PDA) has lost its High Court challenge over changes to professional standards for pharmacists which it claimed threatened a pharmacist’s human rights.

Simon Stevens, chief executive of NHS England

NHS report promises 'over 1,300' pharmacists in GP surgeries by 2019

‘Next steps on the NHS five year forward view’ outlines progress made so far and highlights priorities for the next few years, including plans for 900 clinical pharmacists in GP surgeries by 2018 and over 1,300 by 2019.

Shelves of gluten, dairy and nut free food on shelves in a Tesco store

NHS England to issue guidance on dropping ‘low priority’ drugs from NHS prescriptions

NHS England has identified a number of medicines that should no longer be available on prescription in a move that would save the NHS £128m a year.

Pfizer's product information leaflet for sildenafil citrate, more commonly known under brand name Viagra

MHRA recommends that sildenafil is made available over the counter in the UK

Sildenafil — the prescription-only medicine branded as Viagra for the treatment of erectile dysfunction — could become a pharmacy (P) medicine if government proposals go ahead.

different classes of drugs - polypharmacy

Drug classes commonly implicated in causing kidney injury identified

Researchers have identified the drug classes that are frequently implicated in causing acute kidney injury after analysing adverse drug reactions in a French national pharmacovigilance database.

Female patient using an inhaler

Study identifies most important inhaler technique errors that are linked to poor asthma outcomes

A study of 3,660 patients across eight countries has identified the types of inhaler technique errors that are associated with the greatest impact on asthma outcomes.

News in Brief

Vaughan Gething

Gething confirms community pharmacy funding for Wales

18 APR 2017

The total value of the community pharmacy contract in Wales will remain at £144.3m for the 2017–2018 financial year, health secretary Vaughan Gething has reaffirmed.

Young boy receives HPV vaccine

Boots launches HPV vaccination for boys and men

13 APR 2017

Boots is extending its private human papillomavirus (HPV) vaccination service to make it available to boys and men aged 12–44 years.

The US Food and Drug Administration (FDA)

FDA approves first drug for tardive dyskinesia

12 APR 2017

The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has given the green light to valbenazine (Ingrezza), the first drug to be approved for treating adults with tardive dyskinesia.

General Pharmaceutical Council (GPhC)

GPhC agrees wording for revised standard on religious beliefs

11 APR 2017

The pharmacy regulator is pushing ahead with its controversial proposal to amend professional standards which means pharmacists cannot put their own religious or other beliefs ahead of providing patient-centred care.

Levonelle emergency contraception pill (pictured) is one of the pills thought to be affected by weight

Pharmacists urged to explain potential effect of body weight on emergency contraception

6 APR 2017

The Faculty of Sexual and Reproductive Healthcare (FSRH) has urged pharmacists and doctors to explain to patients that the emergency contraceptive pill can be ineffective in women weighing 11 stone or more, or with a body-mass index of 26 or above.

Students taking an exam

GPhC removes option for registration assessments to be re-marked

31 MAR 2017

The option to have pharmacy registration assessments re-marked will be removed from 2017, the General Pharmaceutical Council (GPhC) has announced.

Patient in a wheelchair

FDA approves first drug for progressive multiple sclerosis

31 MAR 2017

The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of ocrelizumab (Ocrevus; Genentech) for adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

Atopic dermatitis

FDA approves first monoclonal antibody injection for atopic dermatitis

30 MAR 2017

The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of dupilumab (Dupixent; Regeneron Pharmaceuticals) to treat adults with atopic dermatitis.

European Medicines Agency building, Canary Wharf

EMA calls for suspension of generic drugs after concerns about quality of data

28 MAR 2017

A list of generic drugs — including 41 that are available in the UK — have been recommended for suspension across the EU because of doubts over the quality of the bioequivalence data used to grant their national marketing authorisation. 

The Pharmaceutical Journal

April 2017, Vol 298, No 7900

Cover Story:

Smart inhalers: Will they help to improve asthma care?

Read more…

The Pharmaceutical Journal

View previous issue

Your RPS

rps elections hand holding ballot papers illustration 17

If you are elected to the RPS pharmacy board, what will be your top two priorities?Subscription

The results of the RPS national pharmacy board elections are due to be announced at the end of May 2017. In order to get to know this year’s candidates and find out more about what they stand for, The Pharmaceutical Journal asked for responses to two questions. In the first of the two questions, the candidates explain what their top two priorities will be if they are elected to the RPS pharmacy board.  (Of the 23 candidates standing for election, 22 provided responses). 

Illustration of a hand putting vote in ballot box

It’s RPS national board election time againSubscription

By Alex MacKinnon

Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.